The LIGHT molecule (agent) helps providers go from just seeing changes in form and density to delivering more functional biochemical information which facilitates a diagnosis and treatment plan. The radio iodinated phospholipid adheres and lights up the cancer cells.
Improving a providers ability to accurately view and determine a size to the effected area can prove beneficial when calculating the optimal amount of medication to be given when treating the cancer. This helps monitor size and document evidence of the effectiveness of the treatment plan.
If the 2nd trial phase goes well Novelos Therapeutics will announce LIGHT (small molecule) properly identifies a type of brain cancer cells called glioma. Home Care Path and the Wisconsin PATH ALONG Model wish Novelos Therapeutics the best of success in the 2nd trial phase.
Home Care Path celebrates 4 years of successfully serving seniors in South Central Wisconsin
Web site www.homecarepath.com
Twitter https://twitter.com/seniorcareWI
App http://appsmakerstore.com/appim/j6kcdet8xvwk4s
Blog http://homecarepathseniorcare.blogspot.com/
Home Care Path www.homecarepath.com and the Wisconsin PATH ALONG model deliver an advanced supportive care service. Helping seniors in the home, with clinic visits, at the hospital, nursing home and assisted living facility. Helping seniors downsize with a move in to an adult child's home. 2014 rates are 20.00 per hour. Simply call 608-432-4286 to schedule an interview. We can be there when you are working. We accept long term care insurance. Services can be tax deductible. Help with resources and the transition from private payment to public funded programming. Valuing home and human life
No comments:
Post a Comment